4-HO-MiPT: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Tier 2 taxonomy consolidation: merge Classic Psychedelics into Classical Psychedelics (Serotonergic) |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid, extremely tentative)"> | |||
Erowid's dosage documentation for oral 4-HO-MiPT<ref | |||
name="erowid-4homipt-dose">Erowid. 4-HO-MiPT Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/4_ho_mipt/4_ho_mipt_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers, explicitly | |||
marked by Erowid as "EXTREMELY tentative" given the limited number | |||
of reports on which the data are based: | |||
* '''Threshold:''' 5-10 mg | |||
* '''Light:''' 9-14 mg | |||
* '''Common:''' 13-20 mg | |||
* '''Strong:''' 18-30 mg | |||
Onset 20 to 60 minutes after oral ingestion; duration approximately | |||
2 to 3 hours with aftereffects up to 4 hours. Erowid's own caveat | |||
about data reliability should be reflected in any presentation of | |||
these tiers. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | | interactions = <pharmaInteractions/> | ||
| Line 32: | Line 51: | ||
[[Category:Research | [[Category:Research chemicals]] | ||
[[Category:Tryptamines]] | [[Category:Tryptamines]] | ||
[[Category:Classical Psychedelics (Serotonergic)]] | [[Category:Classical Psychedelics (Serotonergic)]] | ||
[[Category:Psychedelics]] | [[Category:Psychedelics]] | ||